SOLID Therapeutics receives Innobooster grant

SOLID Therapeutics shared a post on LinkedIn:

”Funding News!

We’re thrilled to announce that Innovation Fund Denmark has awarded us an Innobooster grant!

This crucial support will accelerate the development of our first in class HCAR1 antagonists, bringing us one step closer to offering new hope to patients battling solid tumors.

We are very grateful to Innovation Fund Denmark for their continued support in our mission.”

Hagop Youssoufian, Founder and Principal of Youssoufian Consulting and Co-Founder of SOLID Therapeutics, shared a post by SOLID Therapeutics, on LinkedIn, adding:

”Enthusiastic congratulations to the SOLID team. I couldn’t be more proud: What a great culture of innovation and collaboration!”

Source: SOLID Therapeutics/LinkedIn and Hagop Youssoufian/LinkedIn